For help on how to get the results you want, see our search tips.
1564 results
Medicine
Shortages Remove Shortages filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine Moderna (updated)
CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021,
, 
, Authorised, Last updated: 26/01/2021
-
List item
Human medicine European public assessment report (EPAR): Viread (updated)
tenofovir disoproxil fumarate, Hepatitis B, Chronic, HIV Infections
Date of authorisation: 04/02/2002, Revision: 55, Authorised, Last updated: 25/01/2021 -
List item
Human medicine European public assessment report (EPAR): Takhzyro (updated)
lanadelumab, Angioedemas, Hereditary
Date of authorisation: 22/11/2018,, 
, 
, Revision: 4, Authorised, Last updated: 25/01/2021
-
List item
Human medicine European public assessment report (EPAR): Ocaliva (updated)
Obeticholic acid, Liver Cirrhosis, Biliary
Date of authorisation: 12/12/2016,, , , Revision: 8, Authorised, Last updated: 25/01/2021
-
List item
Human medicine European public assessment report (EPAR): Bevespi Aerosphere (updated)
glycopyrronium, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 18/12/2018, Revision: 3, Authorised, Last updated: 25/01/2021 -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm GmbH (updated)
clopidogrel, Peripheral Vascular Diseases, Acute Coronary Syndrome, Myocardial Infarction, Stroke
Date of authorisation: 28/07/2009,
, Revision: 12, Withdrawn, Last updated: 25/01/2021
-
List item
Human medicine European public assessment report (EPAR): Ofev (updated)
nintedanib, Idiopathic Pulmonary Fibrosis
Date of authorisation: 14/01/2015,, Revision: 17, Authorised, Last updated: 25/01/2021
-
List item
Human medicine European public assessment report (EPAR): Kovaltry (updated)
octocog alfa, Hemophilia A
Date of authorisation: 18/02/2016, Revision: 10, Authorised, Last updated: 25/01/2021 -
List item
Human medicine European public assessment report (EPAR): Ocrevus (updated)
ocrelizumab, Multiple Sclerosis
Date of authorisation: 08/01/2018,, Revision: 9, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Zerbaxa (updated)
ceftolozane sulfate, tazobactam sodium, Bacterial Infections
Date of authorisation: 18/09/2015, Revision: 13, Authorised, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Symkevi (updated)
tezacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 31/10/2018,, , Revision: 7, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Dupixent (updated)
dupilumab, Dermatitis, Atopic
Date of authorisation: 27/09/2017,, Revision: 9, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Blincyto (updated)
blinatumomab, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 23/11/2015,, , Revision: 11, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Kalydeco (updated)
ivacaftor, Cystic Fibrosis
Date of authorisation: 23/07/2012,, , Revision: 27, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): ViraferonPeg (updated)
peginterferon alfa-2b, Hepatitis C, Chronic
Date of authorisation: 28/05/2000, Revision: 36, Withdrawn, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Tafinlar (updated)
dabrafenib mesylate, Melanoma
Date of authorisation: 26/08/2013, Revision: 22, Authorised, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Tremfya (updated)
guselkumab, Psoriasis
Date of authorisation: 10/11/2017,, Revision: 5, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Tasigna (updated)
nilotinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 19/11/2007, Revision: 38, Authorised, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Ervebo (updated)
recombinant vesicular stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the zaire ebolavirus (strain kikwit 1995) surface glycoprotein, Hemorrhagic Fever, Ebola
Date of authorisation: 11/11/2019,, Revision: 2, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Wakix (updated)
pitolisant, Narcolepsy
Date of authorisation: 31/03/2016,, , Revision: 9, Authorised, Last updated: 21/01/2021
-
List item
Human medicine European public assessment report (EPAR): Zebinix (updated)
eslicarbazepine acetate, Epilepsy
Date of authorisation: 21/04/2009, Revision: 27, Authorised, Last updated: 21/01/2021 -
List item
Human medicine European public assessment report (EPAR): Mysimba (updated)
bupropion hydrochloride, naltrexone hydrochloride, Obesity, Overweight
Date of authorisation: 26/03/2015,, Revision: 18, Authorised, Last updated: 21/01/2021
-
List item
Human medicine European public assessment report (EPAR): Oncaspar (updated)
pegaspargase, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 14/01/2016,, Revision: 12, Authorised, Last updated: 21/01/2021
-
List item
Human medicine European public assessment report (EPAR): Odefsey (updated)
emtricitabine, rilpivirine hydrochloride, tenofovir alafenamide, HIV Infections
Date of authorisation: 21/06/2016, Revision: 17, Authorised, Last updated: 21/01/2021 -
List item
Human medicine European public assessment report (EPAR): Oslif Breezhaler (updated)
indacaterol maleate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 29/11/2009, Revision: 16, Authorised, Last updated: 20/01/2021